Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism

被引:23
作者
Shin, Hae-Won [1 ]
Hong, Sang-Wook [1 ]
Youn, Young Chul [1 ]
机构
[1] Chung Ang Univ, Dept Neurol, Coll Med, 102 Heukseok Ro, Seoul 06973, South Korea
来源
JOURNAL OF CLINICAL NEUROLOGY | 2022年 / 18卷 / 03期
关键词
Parkinsonian disorders; Parkinson's disease; Parkinson-plus syndromes; Parkinson disease; secondary; differential diagnosis; PROGRESSIVE SUPRANUCLEAR PALSY; NORMAL-PRESSURE HYDROCEPHALUS; MULTIPLE SYSTEM ATROPHY; DRUG-INDUCED PARKINSONISM; MESENCHYMAL STEM-CELLS; VASCULAR PARKINSONISM; CORTICOBASAL DEGENERATION; RESEARCH CRITERIA; CONSENSUS STATEMENT; MOVEMENT-DISORDERS;
D O I
10.3988/jcn.2022.18.3.259
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinsonism is a clinical syndrome presenting with bradykinesia, tremor, rigidity, and postural instability. Nonmotor symptoms have recently been included in the parkinsonian syndrome, which was traditionally associated with motor symptoms only. Various pathologically distinct and unrelated diseases have the same clinical manifestations as parkinsonism or parkinsonian syndrome. The etiologies of parkinsonism are classified as neurodegenerative diseases related to the accumulation of toxic protein molecules or diseases that are not neurodegenerative. The former class includes Parkinson's disease (PD), multiple-system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Over the past decade, clinical diagnostic criteria have been validated and updated to improve the accuracy of diagnosing these diseases. The latter class of disorders unrelated to neurodegenerative diseases are classified as secondary parkinsonism, and include drug-induced parkinsonism (DIP), vascular parkinsonism, and idiopathic normal-pressure hydrocephalus (iNPH). DIP and iNPH are regarded as reversible and treatable forms of parkinsonism. However, studies have suggested that the absence of protein accumulation in the nervous system as well as managing the underlying causes do not guarantee recovery. Here we review the differential diagnosis of PD and parkinsonism, mainly focusing on the clinical aspects. In addition, we describe recent updates to the clinical criteria of various disorders sharing clinical symptoms with parkinsonism.
引用
收藏
页码:259 / 270
页数:12
相关论文
共 107 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia [J].
Ando, Shoichiro ;
Kanazawa, Masato ;
Onodera, Osamu .
JOURNAL OF MOVEMENT DISORDERS, 2020, 13 (01) :20-26
[3]   Progressive Supranuclear Palsy: an Update [J].
Armstrong, Melissa J. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (03)
[4]   Criteria for the diagnosis of corticobasal degeneration [J].
Armstrong, Melissa J. ;
Litvan, Irene ;
Lang, Anthony E. ;
Bak, Thomas H. ;
Bhatia, Kailash P. ;
Borroni, Barbara ;
Boxer, Adam L. ;
Dickson, Dennis W. ;
Grossman, Murray ;
Hallett, Mark ;
Josephs, Keith A. ;
Kertesz, Andrew ;
Lee, Suzee E. ;
Miller, Bruce L. ;
Reich, Stephen G. ;
Riley, David E. ;
Tolosa, Eduardo ;
Troester, Alexander I. ;
Vidailhet, Marie ;
Weiner, William J. .
NEUROLOGY, 2013, 80 (05) :496-503
[5]   MDS research criteria for prodromal Parkinson's disease [J].
Berg, Daniela ;
Postuma, Ronald B. ;
Adler, Charles H. ;
Bloem, Bastiaan R. ;
Chan, Piu ;
Dubois, Bruno ;
Gasser, Thomas ;
Goetz, Christopher G. ;
Halliday, Glenda ;
Joseph, Lawrence ;
Lang, Anthony E. ;
Liepelt-Scarfone, Inga ;
Litvan, Irene ;
Marek, Kenneth ;
Obeso, Jose ;
Oertel, Wolfgang ;
Olanow, C. Warren ;
Poewe, Werner ;
Stern, Matthew ;
Deuschl, Guenther .
MOVEMENT DISORDERS, 2015, 30 (12) :1600-1609
[6]  
Boesch SM, 2002, J NEUROL NEUROSUR PS, V72, P300, DOI 10.1136/jnnp.72.3.300
[7]   The Multiple Phenotypes of Corticobasal Syndrome and Corticobasal Degeneration: Implications for Further Study [J].
Boeve, Bradley F. .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (03) :350-353
[8]   Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches [J].
Boxer, Adam L. ;
Yu, Jin-Tai ;
Golbe, Lawrence I. ;
Litvan, Irene ;
Lang, Anthony E. ;
Hoeglinger, Guenter U. .
LANCET NEUROLOGY, 2017, 16 (07) :552-563
[9]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211
[10]   The utility of FDG-PET in the differential diagnosis of Parkinsonism [J].
Brajkovic, Leposava ;
Kostic, Vladimir ;
Sobic-Saranovic, Dragana ;
Stefanova, Elka ;
Jecmenica-Lukic, Milica ;
Jesic, Ana ;
Stojiljkovic, Milica ;
Odalovic, Strahinja ;
Gallivanone, Francesca ;
Castiglioni, Isabella ;
Radovic, Branislava ;
Trajkovic, Goran ;
Artiko, Vera .
NEUROLOGICAL RESEARCH, 2017, 39 (08) :675-684